Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
AIDS Behav ; 20(5): 973-6, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26563760

RESUMO

Linking and retaining people living with HIV in ongoing, HIV medical care is vital for ending the U.S. HIV epidemic. Yet, 41-44 % of HIV+ individuals are out of care. In response, AIDS United initiated Positive Charge, a series of five HIV linkage and re-engagement projects around the U.S. This paper investigates whether three Positive Charge programs were cost effective and calculates a return on investment for each program. It uses standard methods of cost utility analysis and WHO-CHOICE thresholds. All three projects were found to be cost effective, and two were highly cost effective. Cost utility ratios ranged from $4439 to $137,271. These results suggest that HIV linkage to care programs are a productive and efficient use of public health funds.


Assuntos
Fármacos Anti-HIV/economia , Serviços de Saúde Comunitária/economia , Continuidade da Assistência ao Paciente/economia , Análise Custo-Benefício , Infecções por HIV/terapia , Custos de Cuidados de Saúde/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/economia , Fármacos Anti-HIV/uso terapêutico , Chicago , Infecções por HIV/economia , Humanos , Louisiana , Programas Nacionais de Saúde , Cidade de Nova Iorque , Aceitação pelo Paciente de Cuidados de Saúde , Anos de Vida Ajustados por Qualidade de Vida , Estados Unidos
2.
AIDS Behav ; 19(10): 1735-41, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26139421

RESUMO

Positive Charge (PC) is a linkage to HIV care initiative implemented by AIDS United with sites in New York, Chicago, Louisiana, North Carolina, and the San Francisco/Bay Area. This study employed standard methods of cost and threshold analyses, as recommended by the US Panel on Cost-effectiveness in Health and Medicine, to calculate cost-saving and cost effective thresholds of the initiative. The overall societal cost of the linkage to care programs ranged from $48,490 to $370,525. The study found that PC's five unique evidence-based linkage to care programs have relatively low costs per client served and highly achievable cost-saving and cost-effectiveness thresholds. The findings from this study suggest that HIV linkage to care programs have the potential to be a highly productive use of public health resources.


Assuntos
Fármacos Anti-HIV/economia , Serviços de Saúde Comunitária/economia , Continuidade da Assistência ao Paciente/economia , Infecções por HIV/economia , Infecções por HIV/terapia , Custos de Cuidados de Saúde/estatística & dados numéricos , Fármacos Anti-HIV/uso terapêutico , Análise Custo-Benefício/métodos , Medicina Baseada em Evidências , Infecções por HIV/transmissão , Acessibilidade aos Serviços de Saúde , Humanos , Masculino , Modelos Econômicos , Programas Nacionais de Saúde , Avaliação de Processos e Resultados em Cuidados de Saúde , Aceitação pelo Paciente de Cuidados de Saúde , Estados Unidos
3.
AIDS Educ Prev ; 26(5): 429-44, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25299807

RESUMO

The Access to Care (A2C) is a multi-site initiative that seeks to increase the access to and retention in effective HIV healthcare and support services by people living with HIV across the United States. As the initiative implemented evidence-based programs in new settings with diverse populations, it was important to document these innovative efforts to contribute to the evidence base for best practices. In a partnership between Johns Hopkins University, AIDS United, and the A2C sites, a national evaluation strategy was developed and implemented to build knowledge about how linkage to care interventions could be most effectively implemented within the context of local, real-world settings. This article provides an overview of the efforts to develop and implement a national monitoring and evaluation strategy for a multi-site initiative. The findings may be of utility for other HIV interventions that are seeking to incorporate a monitoring and evaluation component into their efforts.


Assuntos
Continuidade da Assistência ao Paciente/organização & administração , Infecções por HIV/terapia , Acessibilidade aos Serviços de Saúde , Aceitação pelo Paciente de Cuidados de Saúde , Avaliação de Programas e Projetos de Saúde/métodos , Comportamento Cooperativo , Medicina Baseada em Evidências , Humanos , Programas Nacionais de Saúde , Formulação de Políticas , Estados Unidos
4.
AIDS Educ Prev ; 25(5): 423-9, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24059879

RESUMO

In fiscal year (FY) 2012, the Centers for Disease Control and Prevention (CDC) reallocated their HIV prevention funding to U.S. states, territories, and some cities so as to be more highly correlated with 2008 HIV prevalence. A jurisdiction's HIV prevention funding could drop as low as $750,000 for FY 2016. Iowa was one state that experienced a substantial funding drop, and it chose to undertake a mathematical modeling exercise to inform the following questions: (a) Given current HIV prevention funding for the state, what is the optimal allocation of resources to maximize infections averted? (b) With this "optimal" resource allocation, how many (and what percentage of) HIV infections in the state can be averted? (c) Is the optimal resource allocation sufficient to achieve the National HIV/AIDS Strategy goal of 25% reduction in HIV incidence? and (d) With the "optimal" resource allocation, is the return on the investment such that it might be considered cost-effective? Here, we describe the results of the policy analysis, and the uses of the results.


Assuntos
Análise Custo-Benefício , Infecções por HIV/economia , Infecções por HIV/prevenção & controle , Alocação de Recursos para a Atenção à Saúde/economia , Serviços Preventivos de Saúde/economia , Centers for Disease Control and Prevention, U.S. , Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , Alocação de Recursos para a Atenção à Saúde/métodos , Política de Saúde/economia , Humanos , Incidência , Iowa/epidemiologia , Modelos Econômicos , Modelos Teóricos , Programas Nacionais de Saúde/organização & administração , Prevalência , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA